首页> 外国专利> Oxycodone and naloxone combination for use in the treatment of pain in patients suffering from diseases that cause pain and intestinal dysbiosis and / or diseases that increase the risk for intestinal bacterial transfer

Oxycodone and naloxone combination for use in the treatment of pain in patients suffering from diseases that cause pain and intestinal dysbiosis and / or diseases that increase the risk for intestinal bacterial transfer

机译：羟考酮和纳洛酮的组合用于治疗患有引起疼痛和肠道功能障碍的疾病和/或增加肠道细菌转移风险的疾病的患者的疼痛

页面导航

摘要
著录项
相似文献

摘要

The invention relates to i) pain and at least one further disease ii) for use in the treatment of pain in a patient suffering from disease ii) resulting in intestinal dysbiosis or i) To the treatment of pain in patients suffering from pain and at least one additional disease iii) that increases the risk of enteric bacterial transfer and thus increases the risk of peritonitis, SIRS and / or sepsis For oral use comprising oxycodone or a pharmaceutically acceptable salt thereof and naloxone or a pharmaceutically acceptable salt thereof.

机译：本发明涉及i）疼痛和至少一种其他疾病ii）用于治疗患有疾病的患者的疼痛ii）导致肠道营养不良或i）治疗患有疼痛的患者的疼痛并且至少一种另外的疾病iii），其增加了肠细菌转移的风险并因此增加了腹膜炎，SIRS和/或败血症的风险。用于口服的包含羟考酮或其药学上可接受的盐和纳洛酮或其药学上可接受的盐。

著录项

公开/公告号JP2016525138A

专利类型
公开/公告日2016-08-22

原文格式PDF
申请/专利权人ユーロ－セルティークエス．エイ．;
展开▼

申请/专利号JP20160528522
发明设计人ヴォンコーブルク;イボンヌ;レイマー;カレン;オクシェ;アレクサンダー;ホルザー;ペーター;
展开▼

申请日2014-07-23
分类号A61K31/485;A61P25/04;A61P1/18;A61P1;A61P37/02;A61P35;A61P1/04;A61P25/16;A61P25;A61P31;A61P3/04;A61P19/02;A61P29;A61P37/08;A61P3/10;A61P31/04;A61P1/16;A61P13/12;A61P17/02;A61K47/10;A61K47/38;A61K9/20;A61K9/48;A61K9/14;A61K9/28;A61K9/16;A61P43;
国家 JP
入库时间 2022-08-21 14:45:56

相似文献

专利
外文文献
中文文献